Tableau de bordPortefeuillesListe de surveillanceCommunautéDécouvrirFiltre
NOT FOR DISTRIBUTION

Mitsui Chemicals, Inc.

TSE:4183 Rapport sur les actions

Capitalisation boursière : JP¥774.0b

  • Présentation de l'entreprise
  • Évaluation
  • Croissance future
  • Performances passées
  • Santé financière
  • Dividende
  • Gestion
  • Propriété
  • Autres informations
  • Communauté boursière

Mitsui Chemicals Croissance future

Future contrôle des critères 2/6

Mitsui Chemicals devrait augmenter ses bénéfices et son chiffre d'affaires de 12% et de 4.9% par an respectivement. Le BPA devrait croître de de 11.8% par an. Le rendement des capitaux propres devrait être 8.9% dans 3 ans.

Informations clés

12.0%

Taux de croissance des bénéfices

11.80%

Taux de croissance du BPA

Chemicals croissance des bénéfices13.0%
Taux de croissance des recettes4.9%
Rendement futur des capitaux propres8.88%
Couverture par les analystes

Good

Dernière mise à jour09 Sep 2026

Mises à jour récentes de la croissance future

Article d’analyse • Aug 07

Analyst Estimates: Here's What Brokers Think Of Mitsui Chemicals, Inc. (TSE:4183) After Its First-Quarter Report

It's been a good week for Mitsui Chemicals, Inc. ( TSE:4183 ) shareholders, because the company has just released its...
Article d’analyse • Feb 08

Earnings Miss: Mitsui Chemicals, Inc. Missed EPS By 63% And Analysts Are Revising Their Forecasts

As you might know, Mitsui Chemicals, Inc. ( TSE:4183 ) last week released its latest quarterly, and things did not turn...

Recent updates

User avatar
Mise à jour du récit • Sep 07

4183: Earnings Guidance And Capital Moves Will Shape A Balanced Outlook

Mitsui Chemicals' analyst price target has shifted from ¥2,350 to about ¥2,435. Analysts point to updated assumptions on fair value, discount rate, profit margins and future P/E as the main drivers of the change.
Article d’analyse • Aug 07

Analyst Estimates: Here's What Brokers Think Of Mitsui Chemicals, Inc. (TSE:4183) After Its First-Quarter Report

It's been a good week for Mitsui Chemicals, Inc. ( TSE:4183 ) shareholders, because the company has just released its...
User avatar
Mise à jour du récit • Jul 30

4183: Treasury Share Disposal Will Support Long Term Upside As Earnings Multiple Re-Rates

Analysts have raised their price target for Mitsui Chemicals from ¥3,000 to about ¥3,355, explaining the change with updated assumptions for revenue growth, profit margins, and future P/E levels. What's in the News Mitsui Chemicals has scheduled a board meeting for Jun 24, 2026 to consider and approve the disposal of treasury shares, along with other business-related matters.
User avatar
Mise à jour du récit • Jul 15

4183: U.S. Oral Care Hub And Richer Multiple Will Limit Future Returns

Analysts have revised their 12 month price target for Mitsui Chemicals from ¥1,550 to ¥1,790, citing updated assumptions for slightly higher revenue growth, improved profit margins, and a modest increase in the future P/E multiple. What’s in the News for Mitsui Chemicals Mitsui Chemicals is shifting its global oral care headquarters to the U.S., aiming to make oral care a core growth pillar and position itself more as a solutions provider for dental patients and professionals.
User avatar
Mise à jour du récit • Jul 01

4183: Buybacks And Treasury Share Disposal Plans Will Shape A Balanced Outlook

The analyst price target for Mitsui Chemicals has been revised from ¥2,251.67 to ¥2,350.00. Analysts cited updated assumptions around revenue growth, profit margin and future P/E as the basis for the change.
User avatar
Mise à jour du récit • Jun 17

4183: Softer Margins And Oral Care Expansion Will Restrain Future Share Returns

Analysts have maintained their fair value estimate for Mitsui Chemicals at ¥1,550, while adjusting key assumptions including a lower discount rate, slightly softer revenue growth and profit margin expectations, and a higher future P/E multiple to reflect the current research backdrop. What’s in the News for Mitsui Chemicals Mitsui Chemicals’ U.S. subsidiary agreed to acquire Ultradent Products to expand the group’s global oral care business, combining Ultradent’s U.S. presence with Mitsui’s Kulzer operations in the EMEA region.
User avatar
Mise à jour du récit • Jun 03

4183: Share Buybacks Will Support Long Term Upside As Earnings Multiple Re-Rates

Analysts are keeping their ¥3,000 price target for Mitsui Chemicals unchanged. They point to small model tweaks in the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in the overall outlook.
User avatar
Mise à jour du récit • May 15

4183: Share Buybacks Will Support Long Term Upside As Earnings Multiple Re-Rates

Analysts have kept their fair value estimate for Mitsui Chemicals steady at ¥3,000 per share. The updated price target reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin and future P/E rather than a major shift in their overall view of the stock.
User avatar
Mise à jour du récit • Apr 26

4183: Weaker Earnings Outlook And Margin Pressure Will Weigh On Future Returns

Analysts have raised Mitsui Chemicals' fair value estimate from ¥1,500 to ¥1,550, citing updated assumptions that combine a slightly higher discount rate and a modestly lower profit margin with a materially higher revenue growth outlook and a marginally lower future P/E multiple. What's in the News Mitsui Chemicals has launched a share repurchase program of up to 18,400,000 shares, or 4.89% of its share capital, for ¥30,000m, with plans to cancel treasury shares after repurchase and a program period running until July 31, 2026 (Key Developments).
User avatar
Mise à jour du récit • Apr 12

4183: Share Buybacks Will Support Long Term Upside Despite Near Term Margin Pressure

Analysts have kept the fair value estimate for Mitsui Chemicals steady at ¥3,000 by refining assumptions on discount rate, revenue growth, profit margin, and future P/E, which together underpin the updated price target narrative. What's in the News Mitsui Chemicals has launched a share repurchase program to buy up to 18,400,000 shares, around 4.89% of its share capital, for ¥30,000m, with plans to cancel the repurchased shares and run the program through July 31, 2026 (Board meeting and buyback transaction announcements, February 5, 2026).
User avatar
Mise à jour du récit • Mar 28

4183: Renewable Plastics And Buybacks Will Support Long Term Share Upside

Analysts have maintained their ¥3,000 price target for Mitsui Chemicals, noting that only minor adjustments to assumptions such as discount rate, revenue growth, profit margin, and future P/E have been made, and these do not materially change their overall view of the shares. What's in the News Mitsui Chemicals is part of a 14 company global supply chain across five countries and regions to produce renewable plastics for Sony's high performance audio visual products, with a focus on tracking and documenting GHG emissions across the chain and supporting Sony's move away from virgin fossil based plastics (Key Developments).
User avatar
Mise à jour du récit • Mar 14

4183: Renewable Plastics Supply Chain Will Reshape Long-Term Earnings Profile

Analysts have reset their price target on Mitsui Chemicals from ¥5,400 to ¥3,000, reflecting updated assumptions for slightly lower discount rates, as well as revised expectations for revenue growth, profit margins, and future P/E levels. What's in the News Mitsui Chemicals joined thirteen other companies across five countries to build what is described as the world's first global supply chain for renewable plastics for use in Sony's high performance audio visual products, allowing tracking of greenhouse gas emissions across the chain and supporting Sony's goal to reduce virgin fossil based plastics (Key Developments).
Article d’analyse • Feb 13

Mitsui Chemicals' (TSE:4183) Conservative Accounting Might Explain Soft Earnings

Shareholders appeared unconcerned with Mitsui Chemicals, Inc.'s ( TSE:4183 ) lackluster earnings report last week. Our...
Article d’analyse • Feb 08

Earnings Miss: Mitsui Chemicals, Inc. Missed EPS By 63% And Analysts Are Revising Their Forecasts

As you might know, Mitsui Chemicals, Inc. ( TSE:4183 ) last week released its latest quarterly, and things did not turn...
Article d’analyse • Feb 05

Why Investors Shouldn't Be Surprised By Mitsui Chemicals, Inc.'s (TSE:4183) P/E

With a price-to-earnings (or "P/E") ratio of 47.9x Mitsui Chemicals, Inc. ( TSE:4183 ) may be sending very bearish...
User avatar
Mise à jour du récit • Feb 05

4183: Decarbonization Investments And Stock Split Plans Will Shape A Balanced Outlook

Analysts have lifted their fair value estimate for Mitsui Chemicals from ¥2,170.83 to ¥2,251.67, citing slightly lower discount rate assumptions, minor adjustments to long term revenue growth and profit margin forecasts, and a modestly higher future P/E multiple. What's in the News Mitsui Chemicals, Asahi Kasei, and Mitsubishi Chemical were selected for Japan's Fiscal 2025 HtA Support Program to support decarbonization and production conversion at two ethylene facilities in western Japan, with a stated investment scale of ¥21.2b and a maximum subsidy application amount of ¥10.4b (HtA Support Program announcement).
User avatar
Mise à jour du récit • Jan 22

4183: Stock Split Plans And Updated Guidance Will Shape A Balanced Outlook

Analysts have revised their price target on Mitsui Chemicals from ¥4,250.91 to ¥2,170.83, citing updated assumptions around slightly lower discount rates, adjusted revenue growth and profit margin expectations, and a modestly different future P/E multiple. What's in the News Mitsui Chemicals has scheduled a board meeting for November 11, 2025, with an agenda that includes discussing a potential stock split (Key Developments).
User avatar
Mise à jour du récit • Jan 07

4183: Future Stock Split And Margin Pressure Will Weigh On Returns

Analysts have adjusted their price target for Mitsui Chemicals from ¥3,000 to ¥1,500, citing updated assumptions for revenue growth, profit margins, and future P/E multiples. What's in the News Mitsui Chemicals scheduled a board meeting for November 11, 2025 to discuss a potential stock split (Key Developments).
Article d’analyse • Dec 03

Mitsui Chemicals (TSE:4183) Has Announced A Dividend Of ¥75.00

Mitsui Chemicals, Inc. ( TSE:4183 ) will pay a dividend of ¥75.00 on the 25th of June. The dividend yield will be 3.9...
Article d’analyse • Oct 23

Investors Appear Satisfied With Mitsui Chemicals, Inc.'s (TSE:4183) Prospects

When close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 14x, you may consider Mitsui...
Article d’analyse • Sep 22

Mitsui Chemicals' (TSE:4183) Dividend Will Be ¥75.00

Mitsui Chemicals, Inc. ( TSE:4183 ) has announced that it will pay a dividend of ¥75.00 per share on the 3rd of...
User avatar
Mise à jour du récit • Sep 21

Specialty Chemicals Restructuring Will Unlock Sustainable Market Potential

The upward revision in Mitsui Chemicals’ price target is underpinned by a marginal improvement in consensus revenue growth forecasts and a slightly higher expected future P/E, resulting in the fair value estimate increasing from ¥4151 to ¥4251. What's in the News Revised H1 2025 earnings guidance: sales revenue JPY 818.0 billion, operating income JPY 31.0 billion, net income JPY 7.5 billion, basic EPS JPY 40.03.
User avatar
Mise à jour du récit • Sep 06

Specialty Chemicals Restructuring Will Unlock Sustainable Market Potential

With Mitsui Chemicals’ consensus analyst price target and key valuation metrics such as the discount rate and future P/E ratio all remaining effectively unchanged, analysts see no material change in fair value, maintaining the target at ¥4151. What's in the News Revised first-half FY2025 guidance: sales revenue expected at JPY 818.0 billion, operating income JPY 31.0 billion, net income JPY 7.5 billion, and basic EPS JPY 40.03.
User avatar
Nouveau récit • Jan 05

Yen Depreciation And Specialty Chemicals Surge Will Propel Operating Income And Revenue Growth

Yen depreciation and improved trade terms are expected to boost operating income in specialty chemicals, positively impacting revenue.

Prévisions de croissance des bénéfices et des revenus

TSE:4183 - Estimations futures des analystes et données financières antérieures (JPY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/20291,972,32083,99859,933210,34110
3/31/20281,900,60568,43378,267223,80011
3/31/20271,892,46252,270-104,70070,80011
6/30/20261,713,45065,74246,700181,587N/A
3/31/20261,668,75434,37875,230212,988N/A
12/31/20251,689,03917,11252,380200,110N/A
9/30/20251,732,40317,85668,488209,738N/A
6/30/20251,775,04315,08271,791206,128N/A
3/31/20251,809,16432,24262,095200,501N/A
12/31/20241,814,04950,44943,929187,747N/A
9/30/20241,816,43951,54144,793193,525N/A
6/30/20241,791,28958,29749,877212,880N/A
3/31/20241,749,74349,9997,362161,339N/A
12/31/20231,725,16655,25133,455172,111N/A
9/30/20231,752,12559,27015,058165,119N/A
6/30/20231,811,35964,535-30,744100,153N/A
3/31/20231,879,54782,936-36,612101,241N/A
12/31/20221,876,52074,869-48,93882,331N/A
9/30/20221,820,23080,403-62,77851,879N/A
6/30/20221,718,21095,358-71,37853,289N/A
3/31/20221,612,688109,990-23,62892,584N/A
12/31/20211,519,376124,939-15,07288,143N/A
9/30/20211,418,281122,21133,137125,836N/A
6/30/20211,327,832102,81573,739152,720N/A
3/31/20211,211,72557,87397,826174,323N/A
12/31/20201,197,36343,821N/AN/AN/A
9/30/20201,201,05235,78879,738151,614N/A
6/30/20201,250,67523,105N/AN/AN/A
3/31/20201,338,98737,944N/A114,974N/A
12/31/20191,367,16845,327N/AN/AN/A
9/30/20191,436,90846,113N/A130,494N/A
6/30/20191,469,44265,163N/AN/AN/A
3/31/20191,482,90976,115N/A109,492N/A
12/31/20181,483,49068,628N/AN/AN/A
9/30/20181,428,58675,161N/A86,972N/A
6/30/20181,375,77172,350N/AN/AN/A
3/31/20181,328,52671,585N/A82,660N/A
12/31/20171,302,04075,678N/AN/AN/A
9/30/20171,264,41075,256N/A82,134N/A
6/30/20171,227,60871,343N/AN/AN/A
3/31/20171,212,28264,839N/A100,440N/A
12/31/20161,182,18539,377N/AN/AN/A
9/30/20161,203,97822,269N/A126,714N/A
6/30/20161,258,48522,353N/AN/AN/A
3/31/20161,343,89822,963N/A145,913N/A
12/31/20151,416,70131,842N/AN/AN/A
9/30/20151,482,76438,358N/A129,793N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 4183 ( 12% par an) est supérieure au taux d'épargne ( 0.9% ).

Bénéfices vs marché: Les bénéfices de 4183 ( 12% par an) devraient croître plus rapidement que le marché JP ( 8.6% par an).

Croissance élevée des bénéfices: Les bénéfices de 4183 devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 4183 ( 4.9% par an) devrait croître plus lentement que le marché de JP ( 6.3% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 4183 ( 4.9% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 4183 devrait être faible dans 3 ans ( 8.9 %).


Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/09/10 12:43
Cours de l'action en fin de journée2026/09/10 00:00
Les revenus2026/06/30
Revenus annuels2026/03/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
  • Formulaire 10-K de la SEC
  • Formulaire 10-Q de la SEC
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
  • Rapports de recherche des analystes
  • Blue Matrix
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
  • Données de marché ICE
  • Formulaire S-1 de la SEC
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
  • Formulaire 4 de la SEC
  • Formulaire 13D de la SEC
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
  • Formulaire 10-K de la SEC
  • Formulaire SEC DEF 14A
Principaux développements10 ans
  • Annonces de l'entreprise
  • Formulaire 8-K de la SEC

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Mitsui Chemicals, Inc. est couverte par 19 analystes. 11 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Mikiya YamadaBarclays
Takashi EnomotoBofA Global Research
Yuta NishiyamaCitigroup Inc

Prenez de meilleures décisions d’investissement partout

Scannez pour télécharger
Ouvrir l’App StoreOuvrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Voir les sources de données
Marchés
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Idées d'investissement
  • Sociétés sous-évaluées
  • Les géants du dividende
  • Achats d'initiés
  • Énergie nucléaire
  • Véhicules autonomes
  • Intelligence artificielle
  • Cryptomonnaie et blockchain
  • cybersécurité
  • Plus d'idées
Communautés boursières
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Outils et fonctionnalités
  • Suivi de portefeuille
  • Filtre et alertes sur les actions
  • Narratives et valeurs équitables
  • Calculateur de dividendes
Actualités et découvertes
  • Dernières actualités de stock
  • Aperçus du marché mondial
  • Le Foxhole
  • Idées d'investissement
  • Narratives de la communauté
  • Quoi de neuf
Simply Wall St
  • Plans et tarifs
  • Publicité
  • À propos de nous
  • Nous contacter
  • Carrières
  • Centre d'aide
  • Apprendre à investir en bourse
  • Programme d'affiliation
  • Affaires et entreprises
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Conditions générales d'utilisation
  • Politique de confidentialité
  • Conditions relatives à l'IA
  • Guide des services financiers